William Fisher & Talha Syed
Set forth below are links to the current drafts of the chapters of a forthcoming book. Citations to these materials should include the phrase, “(partial and preliminary draft).”
Introduction
Chapter 1: The Global Health Crisis
- A. Increasing Threats
- B. Persistent Inequality
- C. The Scourge of Substandard and Falsified Drugs
Chapter 2: How Drugs Are Managed
- A. Upper-Income Countries
- Incentives
- Quality
- Access
- Gaps and Conflicts
- B. Low and Middle-Income Countries
- Background
- Incentives
- Quality
- Access
Chapter 3: Roles and Responsibilities
- A. Global Obligations
- B. Public and Private Actors
Chapter 4: Improving Pharmaceutical Markets
- A. Expediting Approvals
- B. Eliminating Substandard and Falsified Drugs
- C. Reducing Pharmaceutical Hesitancy
Chapter 5: Differential Pricing
- A. The Theory and Practice of Differential Pricing
- B. Differential Pricing in the Pharmaceutical Industry
- C. Reform
Chapter 6: Voluntary Licensing
- A. Successes
- B. Failures
- C. Lessons
Chapter 7: Adjusting Intellectual Property Systems
- A. Developing Countries
- Constraints
- Flexibilities
- Clearing the Path
- B. Developed Countries
- Constraints
- De-Biasing
- Respecting the TRIPS Flexibilities
Chapter 8: Carrots
- A. Grants
- B. Prizes
Chapter 9: Sticks
- A. Rationale
- B. Current Proposals
- Mandatory Research
- Price Regulation
- Foreign Filing Licenses
- C. Benefit Sharing
- D. The Social Responsibility Index